Very impressive quarter with NPAT of $1.6m for Q3.

Record order book of $45m, which continues to grow and margins increasing.

Annual NPAT could easily come in at around $5-6m going forward.

PE of around 20x would be fair for a health stock with this sort of growth, so that would equate to a market cap of around $100-120m and its current market cap is circular $60m

My PRICE TARGET over the next year is $0.33. Let's hope they continue to execute.